OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 87 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,081 | +36.8% | 1,545 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,951 | -79.4% | 1,545 | -78.7% | 0.00% | 0.0% |
| Q4 2021 | $67,794 | -66.0% | 7,243 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $199,617 | +54.6% | 7,243 | +57.0% | 0.00% | +50.0% |
| Q2 2021 | $129,100 | -5.1% | 4,614 | +12.5% | 0.00% | 0.0% |
| Q1 2021 | $136,071 | – | 4,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
| BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
| Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
| Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
| VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
| Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
| Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
| HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
| RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |